{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[
    {
      "abstracts":[
        {
          "abstract":"Huang, Y. et al. Abstract# 128:1756, 2016",
          "link":"http://www.bloodjournal.org/content/128/22/1756?sso-checked=true"
        }
      ],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[],
      "tumorType":{
        "children":{},
        "code":"DLBCLNOS",
        "color":"LimeGreen",
        "id":490,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature B-Cell Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Diffuse Large B-Cell Lymphoma, NOS",
        "parent":"MBN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "24362818",
        "25713363",
        "26366712"
      ],
      "tumorType":{
        "children":{},
        "code":"FL",
        "color":"LimeGreen",
        "id":286,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature B-Cell Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Follicular Lymphoma",
        "parent":"MBN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"KMT2D, a tumor suppressor and histone methyltransferase, is one of the most frequently mutated genes in cancer.",
  "highestDiagnosticImplicationLevel":"LEVEL_Dx3",
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"02/02/2023",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[]
    },
    "description":"",
    "knownEffect":"Unknown"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"R5179C",
    "alterationType":null,
    "consequence":null,
    "entrezGeneId":8085,
    "hgvs":null,
    "hugoSymbol":"KMT2D",
    "id":null,
    "proteinEnd":null,
    "proteinStart":null,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The biologic significance of the KMT2D R5179C mutation is unknown (last reviewed 02/02/2023). However, it has been identified as a statistically significant hotspot and is likely to be oncogenic.",
  "vus":true
}